Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
Stem Cell Reports
; 17(4): 993-1008, 2022 04 12.
Article
in En
| MEDLINE
| ID: mdl-35276091
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Induced Pluripotent Stem Cells
Limits:
Humans
Language:
En
Journal:
Stem Cell Reports
Year:
2022
Document type:
Article
Affiliation country: